Emergent BioDefense Operations Lansing Inc.; est. no. 1755

Emergent BioDefense Operations Lansing Inc. - 3500 North Martin Luther King, Jr., Blvd., P.O. Box 30035, Lansing, MI 48909; also a facility in Spokane, WA; a subsidiary of Emergent Biosolutions Inc.; formerly BioPort Corp. (est no. 1260); before that the Michigan Biologics Products Institute (MBPI; est. no. 0099); before that, the Michigan Department of Public Health; MBPI was acquired from the State of Michigan by BioPort on Sept. 4, 1998

Related product monographs:

1. Anthrax Vaccine -- Manuf. ; R&D ; Tech.
2. Botulinum Toxoids -- Manuf. ; R&D ; Tech.
3. Diphtheria Toxoid/BioPort -- Manuf. ; R&D ; Tech. ; Former
4. Diphtheria & Tetanus Toxoids/BioPort -- Manuf. ; R&D ; Tech. ; Former
5. DTP Vaccine/BioPort -- Former
6. Pertussis Vaccine Adsorbed -- Manuf. ; R&D ; Tech.
7. Rabies Vaccine/BioPort -- Manuf. ; Former
8. Tetanus Toxoid Adsorbed/BioPort -- Former
9. Factor VIII/BioPort -- Manuf. ; Tech. ; Former
10. Anthrax immune globulin/Emergent -- Manuf. ; R&D ; Tech.

Location - Lansing MI 48909 USA

Further information:
Description, ordering information, etc.
Order/Inquiry
Products Database

Copyright ©2020. Biotechnology Information Institute